Skip to content
GH·Nasdaq·US

Guardant Health

Guardant Health develops and commercializes blood- and tissue-based precision oncology tests for cancer detection, treatment selection, residual disease monitoring, and screening. The company generates revenue primarily from oncology testing services and related biopharma and screening offerings.

Thematic Position

GH

Relationship Groups

Suppliers1
Customers1
Partners1
Competitors11

Relationship details are part of the Pro plan.

Ended Relationships

4 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

regulatory approvalmarket access restriction
Multiple state laboratory licensure requirements constrain Guardant Health's interstate testing operations
SEC 10-KFeb 19, 2026

The full regulatory passage is part of the Pro plan.

18 more · Regulatory and geopolitical insights are part of the Pro plan.